Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-020844
Filing Date
2017-03-15
Accepted
2017-03-15 17:00:25
Documents
1
Period of Report
2017-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3232
  Complete submission text file 0001209191-17-020844.txt   4532
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1880 ELLINGTON WAY AUBURN AL 36830
Business Address
Lawrence Thomas R (Reporting) CIK: 0001408568 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 17691911